BSF Enterprise (BSFA) Share Price, News & Analysis

Company Overview

BSF Enterprise Plc does not have significant operations. The company intends to acquire the businesses within biotechnology, innovative marketing, and e-commerce sectors. BSF Enterprise Plc was incorporated in 2018 and is based in London, United Kingdom.

Key Stats

• Today's Range: 1.91 to 2.23
• 50-Day Range: 1.25 to 3.46
• 52-Week Range: 1.25 to 6.45
• Volume: 589,841 shs
• Average Volume: 947,218 shs
• Market Capitalization: £2.75 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BSFA Stock Analysis - Frequently Asked Questions

How have BSFA shares performed this year?

BSF Enterprise's stock was trading at GBX 2.40 at the beginning of 2025. Since then, BSFA shares have decreased by 7.1% and is now trading at GBX 2.23.
View the best growth stocks for 2025 here.

How were BSF Enterprise's earnings last quarter?

BSF Enterprise Plc (LON:BSFA) announced its quarterly earnings results on Friday, January, 31st. The company reported ($1.62) earnings per share (EPS) for the quarter. BSF Enterprise had a negative trailing twelve-month return on equity of 47.59% and a negative net margin of 2,542.63%.

How do I buy shares of BSF Enterprise?

Shares of BSFA stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of BSF Enterprise own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BSF Enterprise investors own include Pharos Energy (PHAR) and Altitude Group (ALT).

Company Calendar

• Last Earnings: 1/31/2025
• Today: 5/22/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: LON:BSFA
• CIK: N/A
• Web: www.bsfenterprise.com
• Phone: 44 20 3283 4590
• Fax: N/A
• Employees: 12
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (1.65)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-2,040,477.60
• Net Margins: -2,542.63%
• Pretax Margin: N/A
• Return on Equity: -47.59%
• Return on Assets: -20.65%

Debt

• Debt-to-Equity Ratio: 2.45
• Current Ratio: 2.96
• Quick Ratio: 1.33

Sales & Book Value

• Annual Sales: £80,250.74
• Price / Sales: 34.27
• Cash Flow: GBX 0.22 per share
• Price / Cash Flow: 10.30
• Book Value: GBX 3.09 per share
• Price / Book: 0.72

Miscellaneous

• Outstanding Shares: 123,336,000
• Free Float: N/A
• Market Cap: £2.75 million
• Optionable: Not Optionable
• Beta: 1.71